Biolase receives patent for laser technology use in eye surgery

The U.S. Patent and Trademark Office has issued Biolase a new patent (#7,867,223) covering the use of its laser technologies for treating presbyopia and hyperopia. Titled "Methods for Treating Hyperopia and Presbyopia via Laser Tunneling," the patent covers the use of erbium-based pulsed lasers to increase or facilitate an increase in accommodation, mitigating the effects of presbyopia and enabling the eye to refocus at near distance without losing its ability to focus at a distance.

This new patent is Biolase's first U.S. patent to be issued in its Ophthalmic Patent Family IV and is one of a total of seven issued and 20 pending U.S. and international patents in the four families in the field of ophthalmology. Specific claims include the company's Waterlase Er,Cr:YSGG laser technology.

Unlike other approaches to treating presbyopia utilizing lasers, the Waterlase method does not involve altering the cornea or lens, according to Federico Pignatelli, Biolase chairman and CEO. The method restores normal accommodative function, thereby improving near, intermediate and distance vision. There are no issues with glare, depth perception, or intermediate vision, and patients retain natural binocular stereoscopic vision.


Posted by Lee Mather

Follow us on Twitter, Facebook, and LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

(SLIDESHOW) View the July/August 2013 issue

Sales of Coherent lasers for ophthalmology exceed 10,000 units

Coherent has now shipped over 10,000 lasers into ophthalmic applications, including pulsed excimer ultraviolet lasers for LASIK vision correction and continuous-wave (CW) solid-state lasers with gr...

WaveTec Vision secures $16.5M to market cataract surgery system

WaveTec Vision has closed a new round of financing for its recently introduced ORA System, a wavefront aberrometry system for cataract surgery, securing an additional $16.5 million.

Anterior segment module receives FDA clearance

Heidelberg Engineering has gained FDA clearance for its Spectralis anterior segment module, which provides high-resolution images of the cornea, anterior chamber angle, and sclera using the company...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS